Breast Cancer Statistics and Screening Challenges - Globally, breast cancer caused 670,000 deaths in 2022, with 11,500 deaths in the UK, equating to 32 deaths per day, and cases are predicted to rise to 70,000 by 2040 [1] - While death rates are falling by 44% due to interventions, better screening, and treatments, low screening uptake remains a concern, especially among underserved populations [1] - NHS backlogs, exacerbated by decades of underfunding and COVID-19, contribute to reduced resources and disproportion between screenings needed and available radiologists and mammographic equipment [1] - Accessibility problems are significantly worse for underserved populations, with cultural unacceptability, invasiveness, fear of radiation, and pain deterring women from undergoing mammography [1] - A survey revealed that 21% of 2,000 women cited embarrassment and fear of pain as reasons for avoiding screening [1] Fingerprint-Based Breast Cancer Screening Innovation - A novel fingerprint-based test is proposed as a non-invasive, radiation-free, and painless alternative to mammography, bypassing NHS backlogs and resource constraints [1] - The technology utilizes mass spectrometry (MALDI) to analyze molecular patterns in fingerprints, identifying proteins indicative of an individual's state, including potential biomarkers for breast cancer [1] - Research demonstrated the ability to differentiate between male and female fingerprints with 86% accuracy by analyzing protein profiles [2] - A study involving 135 samples from 15 women showed that a machine learning algorithm could distinguish between early breast cancer, benign conditions, and metastatic cancer with 97.8% accuracy [2] - The fingerprint test aims to reduce NHS costs, increase accessibility (potentially at GP practices or at home), improve compliance, and ultimately save lives [2]

Core Viewpoint - Johnson Controls International plc (JCI) has announced a $9 billion share buyback program, reflecting its commitment to rewarding shareholders [1][2]. Share Buyback Program - The board of directors has authorized the repurchase of $9 billion worth of shares, which can be executed in the open market or through various methods, including Rule 10b-5-1 trading plans, with no expiration date [2][9]. - JCI currently has an existing share repurchase program from 2021, with $1.1 billion remaining as of the end of the second quarter of fiscal 2025 [3][9]. Financial Performance - In the first half of fiscal 2025, JCI repurchased 8.2 million shares for $660 million and paid out $489 million in dividends [4][9]. - The company has a market capitalization of $69 billion and holds a Zacks Rank of 3 (Hold) [5]. Market Position and Growth - JCI has experienced a 24.6% increase in share price over the past six months, significantly outperforming the industry growth of 1.5% [7]. - The Building Solutions North America segment is showing solid momentum, driven by increased demand for the HVAC platform and investments in digital offerings like the OpenBlue platform [5]. Challenges - Rising selling, general and administrative (SG&A) expenses due to higher transformation and transaction costs may impact profitability [7]. - High debt levels could increase financial obligations for the company [7].

BNP Paribas share buyback programme Declaration of transactions in own shares from June 9, 2025 to June 13, 2025 PRESS RELEASE Paris, 16 June 2025 In accordance with Article 5 of Regulation (EU) No 596/2014 on Market Abuse and Article 3 (3) of Delegated Regulation (EU) 2016/1052 supplementing Regulation (EU) No 596/2014 through regulatory technical standards concerning the conditions applicable to buyback programs and stabilization measures, BNP Paribas informs the market of the following transactions in ...

Key Takeaways KEX saw Q1 2025 revenues edge up 0.15% as tight capacity boosted barge rates and utilization. A $97.3M vessel acquisition expands capacity amid strong demand, especially in specialty markets. Operational delays and rising costs from weather, labor shortages and inflation hurt margins.Kirby Corporation (KEX) is thriving with strong demand, which is boosting its prospects. Shareholder-friendly initiatives and robust liquidity are encouraging. However, KEX is grappling with economic uncertainti ...

Core Viewpoint - VEON Ltd. is initiating the third phase of its share buyback program, amounting to up to USD 35 million, following the successful completion of the second phase [1][2][3] Share Buyback Program - The second phase of the buyback program was completed on May 21, 2025, resulting in the repurchase of 1.43 million American Depositary Shares (ADSs) at an average price of USD 45.59 per ADS [2] - The total share buyback program announced on August 1, 2024, is valued at up to USD 100 million [2][3] - The company believes its ADSs are undervalued compared to its operational performance and strategic potential, aiming to optimize shareholder value through this buyback [3] Financial Strategy - VEON is exploring options for raising external financing through a private placement of bonds with a tenor of up to approximately four years, aimed at supporting strategic initiatives and enhancing financial flexibility [4] - Discussions with potential institutional investors are ongoing as part of the company's capital planning efforts [4] Company Overview - VEON operates as a digital operator providing connectivity and digital services to nearly 160 million customers across six countries, representing over 7% of the global population [5]

Core Viewpoint - Sydbank A/S has initiated a share buyback program amounting to DKK 1,350 million, aimed at reducing its share capital, which commenced on March 3, 2025, and is set to conclude by January 31, 2026 [1][2]. Group 1: Share Buyback Program Details - The share buyback program is executed in compliance with the Safe Harbour rules as per Regulation (EU) No 596/2014 and Commission Delegated Regulation (EU) 2016/1052 [2]. - As of the latest announcement, a total of 1,029,000 shares have been repurchased, with a gross value of DKK 434,479,100 [2][4]. - In week 24, Sydbank A/S repurchased 46,000 shares, with a total gross value of DKK 20,545,050 [2]. Group 2: Transaction Breakdown - The transactions for week 24 included: - June 10, 2025: 12,000 shares at a VWAP of DKK 444.43, gross value DKK 5,333,160 - June 11, 2025: 12,000 shares at a VWAP of DKK 445.49, gross value DKK 5,345,880 - June 12, 2025: 11,000 shares at a VWAP of DKK 448.37, gross value DKK 4,932,070 - June 13, 2025: 11,000 shares at a VWAP of DKK 448.54, gross value DKK 4,933,940 [2]. - Following these transactions, Sydbank A/S holds a total of 1,030,375 own shares, representing 2.01% of the bank's share capital [4].

Core Points - Danske Bank has initiated a share buy-back programme totaling DKK 5 billion, with a maximum of 45 million shares to be repurchased from February 10, 2025, to January 30, 2026 [1][2] - The programme is compliant with the Market Abuse Regulation and the Safe Harbour Rules [2] - In week 24, a total of 228,941 shares were repurchased at an average price of DKK 258.3836, amounting to a gross value of DKK 59,154,595 [3][4] - The total number of shares repurchased under the programme has reached 6,905,843, representing 0.821% of Danske Bank's share capital [4]

Group 1 - The share buyback program is set to run from June 2, 2025, to January 30, 2026, with a total buyback amount of up to DKK 1,000 million, limited to a maximum of 1,600,000 shares [1][2] - As of the latest announcement, a total of 460,600 shares have been repurchased, representing 1.81% of the bank's share capital [2][3] - The average purchase price for shares bought back under the program is DKK 1,221.88, with a total expenditure of DKK 562,795,720 [2] Group 2 - The transactions conducted under the share buyback program comply with EU regulations, specifically EU Commission Regulation No. 596/2014 and EU Commission Delegated Regulation No. 2016/1052 [2] - Detailed transaction data shows that on June 10, 2025, a total of 46,400 shares were purchased at an average price of DKK 1,353.60, amounting to DKK 62,807,014 [2][4] - The bank's trading portfolio and customer investments are excluded from the total shares owned under the buyback program [2]

Company announcement no. 34 / 2025Schindellegi, Switzerland – 16 June 2025 Trifork Group: Weekly report on share buyback On 28 February 2025, Trifork initiated a share buyback program in accordance with Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and Commission Delegated Regulation (EU) 2016/1052, (Safe Harbour regulation). The share buyback program runs from 4 March 2025 up to and including no later than 30 June 2025. For details, please see company announcement no ...

Core Viewpoint - Thermo Fisher Scientific is considering selling part of its diagnostics business due to industry concerns over federal spending cuts on research, with a target sale price of around $4 billion [1][2]. Company Summary - The diagnostics unit of Thermo Fisher produces infectious disease testing equipment and is currently under evaluation for potential sale to private equity firms [2][3]. - The company has experienced a 20% decline in its shares this year, while competitors Danaher and Becton, Dickinson and Company have seen declines of 11% and 23%, respectively [4]. - In the first quarter, Thermo Fisher reported a year-over-year organic revenue growth of 1% [4]. - The CEO of Thermo Fisher expressed pride in the company's strong performance amid a challenging macroeconomic environment [5]. Industry Summary - The healthcare sector is facing volatility due to concerns about the impact of federal budget cuts on research funding, particularly cuts proposed by President Donald Trump to the National Institutes of Health [3]. - Becton, Dickinson and Company announced plans to separate its life sciences business, which includes a diagnostics segment, to enhance focus and value [6][7].